Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
D 5.38 -1.47% -0.08
TLC closed down 1.47 percent on Friday, May 14, 2021, on 9 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical TLC trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -1.47%
Crossed Above 200 DMA Bullish -1.47%
Stochastic Buy Signal Bullish -1.47%
Pocket Pivot Bullish Swing Setup -1.47%
Oversold Stochastic Weakness -1.47%
200 DMA Resistance Bearish 9.35%
Lower Bollinger Band Walk Weakness 9.35%
Older End-of-Day Signals for TLC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taiwan Liposome Company, Ltd. Description

Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Drugs Pharmaceutical Products Inflammation Pharmacology Ophthalmic Ophthalmology Drug Delivery Lipid Icos Macular Edema Arthritis Bupivacaine Drug Delivery System Corticosteroid Doxorubicin Fungal Infection Local Anesthetic Liposome Peripheral Arterial Disease Treatment Of Inflammation Amphotericin B

Is TLC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.65
52 Week Low 4.07
Average Volume 18,344
200-Day Moving Average 5.02
50-Day Moving Average 5.62
20-Day Moving Average 5.51
10-Day Moving Average 5.27
Average True Range 0.28
ADX 16.24
+DI 21.93
-DI 20.43
Chandelier Exit (Long, 3 ATRs ) 5.25
Chandelier Exit (Short, 3 ATRs ) 5.76
Upper Bollinger Band 6.11
Lower Bollinger Band 4.91
Percent B (%b) 0.39
BandWidth 21.81
MACD Line -0.14
MACD Signal Line -0.12
MACD Histogram -0.0247
Fundamentals Value
Market Cap 226.38 Million
Num Shares 42.1 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -10.63
Price-to-Sales 50.63
Price-to-Book 7.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.56
Resistance 3 (R3) 5.58 5.54 5.53
Resistance 2 (R2) 5.54 5.49 5.53 5.52
Resistance 1 (R1) 5.46 5.47 5.44 5.44 5.51
Pivot Point 5.42 5.42 5.41 5.41 5.42
Support 1 (S1) 5.34 5.37 5.32 5.32 5.25
Support 2 (S2) 5.30 5.35 5.29 5.24
Support 3 (S3) 5.22 5.30 5.23
Support 4 (S4) 5.20